Advertisement
Review Article| Volume 34, ISSUE 3, P453-477, September 2014

Clinical Use of the Activated Partial Thromboplastin Time and Prothrombin Time for Screening

A Review of the Literature and Current Guidelines for Testing

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Halbmayer W.M.
        • Haushofer A.
        • Schon R.
        • et al.
        The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: evaluation of the incidence of FXII deficiency among 300 healthy blood donors.
        Thromb Haemost. 1994; 71: 68-72
        • Munro J.
        • Booth A.
        • Nicholl J.
        Routine preoperative testing: a systematic review of the evidence.
        Health Technol Assess. 1997; 1 (1–62): i-iv
        • Reeves B.C.
        • Ascione R.
        • Chamberlain M.H.
        • et al.
        Effect of body mass index on early outcomes in patients undergoing coronary artery bypass surgery.
        J Am Coll Cardiol. 2003; 42: 668-676
        • Chee Y.L.
        • Crawford J.C.
        • Watson H.G.
        • et al.
        Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. British Committee for Standards in Haematology.
        Br J Haematol. 2008; 140: 496-504
        • Shetty S.
        • Ghosh K.
        • Mohanty D.
        Comparison of four commercially available activated partial thromboplastin time reagents using a semi-automated coagulometer.
        Blood Coagul Fibrinolysis. 2003; 14: 493-497
        • Clinical and Laboratory Standards Institute
        Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline.
        (CLSI document C28-A3)3rd edition. Clinical and Laboratory Standards Institute, Wayne (PA)2008
        • Schouwers S.M.
        • Delanghe J.R.
        • Devreese K.M.
        Lupus Anticoagulant (LAC) testing in patients with inflammatory status: does C-reactive protein interfere with LAC test results?.
        Thromb Res. 2010; 125: 102-104
      1. World Health Organization (WHO). WHO Expert Committee on Biological Standardization – Thirty-Third report. Annex 3, WHO Technical Report Series, no. 687 – Requirements for thromboplastins and plasma used to control oral anticoagulant therapy (Requirements for Biological Substances no. 30, revised 1982). 1983. Available at: http://onlinelibrary.wiley.com/doi/10.1111/j.1538-7836.2004.00775.x/pdf. Accessed December 5, 2013.

        • Sosothikul D.
        • Seksarn P.
        • Lusher J.M.
        Pediatric reference values for molecular markers in hemostasis.
        J Pediatr Hematol Oncol. 2007; 29: 19-22
      2. Preoperative routines. The Swedish Council on Technology Assessment in Health Care.
        Int J Technol Assess Health Care. 1991; 7: 95-100
        • Peterson P.
        • Hayes T.E.
        • Arkin C.F.
        • et al.
        The preoperative bleeding time test lacks clinical benefit: College of American Pathologists' and American Society of Clinical Pathologists' position article.
        Arch Surg. 1998; 133: 134-139
        • Chee Y.L.
        • Greaves M.
        Role of coagulation testing in predicting bleeding risk.
        Hematol J. 2003; 4: 373-378
        • Eckman M.H.
        • Erban J.K.
        • Singh S.K.
        • et al.
        Screening for the risk for bleeding or thrombosis.
        Ann Intern Med. 2003; 138: W15-W24
        • Dzik W.H.
        Predicting hemorrhage using preoperative coagulation screening assays.
        Curr Hematol Rep. 2004; 3: 324-330
        • Sié P.
        • Steib A.
        Central laboratory and point of care assessment of perioperative hemostasis.
        Can J Anaesth. 2006; 53: S12-S20
        • Kozek-Langenecker S.A.
        Perioperative coagulation monitoring.
        Best Pract Res Clin Anaesthesiol. 2010; 24: 27-40
        • Klopfenstein C.E.
        Preoperative clinical assessment of hemostatic function in patients scheduled for a cardiac operation.
        Ann Thorac Surg. 1996; 62: 1918-1920
        • Krishna P.
        • Lee D.
        Post-tonsillectomy bleeding: a meta-analysis.
        Laryngoscope. 2001; 111: 1358-1361
        • Eisenberg J.M.
        • Clarke J.R.
        • Sussman S.A.
        Prothrombin and partial thromboplastin times as preoperative screening tests.
        Arch Surg. 1982; 117: 48-51
        • Borzotta A.P.
        • Keeling M.M.
        Value of the preoperative history as an indicator of hemostatic disorders.
        Ann Surg. 1984; 200: 648-652
        • Rohrer M.J.
        • Michelotti M.C.
        • Nahrwold D.L.
        A prospective evaluation of the efficacy of preoperative coagulation testing.
        Ann Surg. 1988; 208: 554-557
        • Macpherson C.R.
        • Jacobs P.
        • Dent D.M.
        Abnormal peri-operative haemorrhage in asymptomatic patients is not predicted by laboratory testing.
        S Afr Med J. 1993; 83: 106-108
        • Houry S.
        • Georgeac C.
        • Hay J.M.
        • et al.
        A prospective multicenter evaluation of preoperative hemostatic screening tests. The French Associations for Surgical Research.
        Am J Surg. 1995; 170: 19-23
        • Koscielny J.
        • Ziemer S.
        • Radtke H.
        • et al.
        A practical concept for preoperative identification of patients with impaired primary hemostasis.
        Clin Appl Thromb Hemost. 2004; 10: 195-204
        • Murray D.
        • Pennell B.
        • Olson J.
        Variability of prothrombin time and activated partial thromboplastin time in the diagnosis of increased surgical bleeding.
        Transfusion. 1999; 39: 56-62
        • Colon-Otero G.
        • Gilchrist G.S.
        • Holcomb G.R.
        • et al.
        Preoperative evaluation of hemostasis in patients with congenital heart disease.
        Mayo Clin Proc. 1987; 62: 379-385
        • Ferraris V.A.
        • Gildengorin V.
        Predictors of excessive blood use after coronary artery bypass grafting. A multivariate analysis.
        J Thorac Cardiovasc Surg. 1989; 98: 492-497
        • Gravlee G.P.
        • Arora S.
        • Lavender S.W.
        • et al.
        Predictive value of blood clotting tests in cardiac surgical patients.
        Ann Thorac Surg. 1994; 58: 216-221
        • Williams G.D.
        • Bratton S.L.
        • Riley E.C.
        • et al.
        Coagulation tests during cardiopulmonary bypass correlate with blood loss in children undergoing cardiac surgery.
        J Cardiothorac Vasc Anesth. 1999; 13: 398-404
        • Aghajanian A.
        • Grimes D.A.
        Routine prothrombin time determination before elective gynecologic operations.
        Obstet Gynecol. 1991; 78: 837-839
        • Bolger W.E.
        • Parsons D.S.
        • Potempa L.
        Preoperative hemostatic assessment of the adenotonsillectomy patient.
        Otolaryngol Head Neck Surg. 1990; 103: 396-405
        • Burk C.D.
        • Miller L.
        • Handler S.D.
        • et al.
        Preoperative history and coagulation screening in children undergoing tonsillectomy.
        Pediatrics. 1992; 89: 691-695
        • Close H.L.
        • Kryzer T.C.
        • Nowlin J.H.
        • et al.
        Hemostatic assessment of patients before tonsillectomy: a prospective study.
        Otolaryngol Head Neck Surg. 1994; 111: 733-738
        • Kang J.
        • Brodsky L.
        • Danziger I.
        • et al.
        Coagulation profile as a predictor for post-tonsillectomy and adenoidectomy (T + A) hemorrhage.
        Int J Pediatr Otorhinolaryngol. 1994; 28: 157-165
        • Zagólski O.
        Post-tonsillectomy haemorrhage–do coagulation tests and coagulopathy history have predictive value?.
        Acta Otorrinolaringol Esp. 2010; 61 ([in Spanish]): 287-292
        • Suchman A.L.
        • Mushlin A.I.
        How well does the activated partial thromboplastin time predict postoperative hemorrhage?.
        JAMA. 1986; 256: 750-753
        • Gewirtz A.S.
        • Miller M.L.
        • Keys T.F.
        The clinical usefulness of the preoperative bleeding time.
        Arch Pathol Lab Med. 1996; 120: 353-356
        • Reddy N.M.
        • Hall S.W.
        • MacKintosh F.R.
        Partial thromboplastin time: prediction of adverse events and poor prognosis by low abnormal values.
        Arch Intern Med. 1999; 159: 2706-2710
        • Ng K.F.
        • Lai K.W.
        • Tsang S.F.
        Value of preoperative coagulation tests: reappraisal of major noncardiac surgery.
        World J Surg. 2002; 26: 515-520
        • Wojtkowski T.A.
        • Rutledge J.C.
        • Matthews D.C.
        The clinical impact of increased sensitivity PT and APTT coagulation assays.
        Am J Clin Pathol. 1999; 112: 225-232
        • Genecov D.G.
        • Por Y.C.
        • Barcelo C.R.
        • et al.
        Preoperative screening for coagulopathy using prothrombin time and partial thromboplastin time in patients requiring primary cranial vault remodeling.
        Plast Reconstr Surg. 2005; 116: 389-394
        • De Saint Blanquat L.
        • Simon L.
        • Laplace C.
        • et al.
        Preoperative coagulation tests in former preterm infants undergoing spinal anaesthesia.
        Paediatr Anaesth. 2002; 12: 304-307
        • Horlocker T.T.
        • Nuttall G.A.
        • Dekutoski M.B.
        • et al.
        The accuracy of coagulation tests during spinal fusion and instrumentation.
        Anesth Analg. 2001; 93: 33-38
        • Schramm B.
        • Leslie K.
        • Myles P.S.
        • et al.
        Coagulation studies in preoperative neurosurgical patients.
        Anaesth Intensive Care. 2001; 29: 388-392
        • Howells 2nd, R.C.
        • Wax M.K.
        • Ramadan H.H.
        Value of preoperative prothrombin time/partial thromboplastin time as a predictor of postoperative hemorrhage in pediatric patients undergoing tonsillectomy.
        Otolaryngol Head Neck Surg. 1997; 117: 628-632
        • Manning S.C.
        • Beste D.
        • McBride T.
        • et al.
        An assessment of preoperative coagulation screening for tonsillectomy and adenoidectomy.
        Int J Pediatr Otorhinolaryngol. 1987; 13: 237-244
        • Zwack G.C.
        • Derkay C.S.
        The utility of preoperative hemostatic assessment in adenotonsillectomy.
        Int J Pediatr Otorhinolaryngol. 1997; 39: 67-76
        • Asaf T.
        • Reuveni H.
        • Yermiahu T.
        • et al.
        The need for routine pre-operative coagulation screening tests (prothrombin time PT/partial thromboplastin time PTT) for healthy children undergoing elective tonsillectomy and/or adenoidectomy.
        Int J Pediatr Otorhinolaryngol. 2001; 61: 217-222
        • Jonnavithula N.
        • Durga P.
        • Pochiraju R.
        • et al.
        Routine preoperative coagulation screening detects a rare bleeding disorder.
        Anesth Analg. 2009; 108: 76-78
        • Hattersley P.G.
        The activated coagulation time of whole blood as a routine pre-operative sceening test.
        Calif Med. 1971; 114: 15-18
        • Wieland A.
        • Belden L.
        • Cunningham M.
        Preoperative coagulation screening for adenotonsillectomy: a review and comparison of current physician practices.
        Otolaryngol Head Neck Surg. 2009; 140: 542-547
      3. American Academy of Otolaryngology - Head and Neck Surgery. Clinical Indicators Compendium. 2009. Available at: https://www.entnet.org/content/clinical-indicato. Accessed December 12, 2013.

        • Baker R.
        Pre-operative hemostatic assessment and management.
        Transfus Apher Sci. 2002; 27: 45-53
      4. Reeves B. Clinical guideline 3. Preoperative tests. The use of routine preoperative tests for elective surgery: London: National Institute for Clinical Excellence; Available at: http://guidance.nice.org.uk/CG3/Guidance/pdf/English. Accessed December 12, 2013.

        • Kamal A.H.
        • Tefferi A.
        • Pruthi R.K.
        How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults.
        Mayo Clin Proc. 2007; 82: 864-873
        • Levy J.H.
        • Dutton R.P.
        • Hemphill 3rd, J.C.
        • et al.
        Multidisciplinary approach to the challenge of hemostasis.
        Anesth Analg. 2010; 110: 354-364
        • De Hert S.
        • Imberger G.
        • Carlisle J.
        • et al.
        Preoperative evaluation of the adult patient undergoing non-cardiac surgery: guidelines from the European Society of Anaesthesiology.
        Eur J Anaesthesiol. 2011; 28: 684-722
        • Webster P.S.
        • Oleson Jr., F.B.
        • Paterson D.L.
        • et al.
        Interaction of daptomycin with two recombinant thromboplastin reagents leads to falsely prolonged patient prothrombin time/International Normalized Ratio results.
        Blood Coagul Fibrinolysis. 2008; 19: 32-38
        • Briselli M.F.
        • Ellman L.
        Kaolin-correctable prolongation of the activated partial thromboplastin time.
        Am J Clin Pathol. 1980; 74: 677-680
        • Milos M.
        • Herak D.C.
        • Zadro R.
        Discrepancies between APTT results determined with different evaluation modes on automated coagulation analyzers.
        Int J Lab Hematol. 2010; 32: 33-39
        • Adcock D.
        • Kressin D.
        • Marlar R.A.
        The effect of time and temperature variables on routine coagulation tests.
        Blood Coagul Fibrinolysis. 1998; 9: 463-470
        • Salvagno G.L.
        • Lippi G.
        • Montagnana M.
        • et al.
        Influence of temperature and time before centrifugation of specimens for routine coagulation testing.
        Int J Lab Hematol. 2009; 31: 462-467
        • Rao L.V.
        • Okorodudu A.O.
        • Petersen J.R.
        • et al.
        Stability of prothrombin time and activated partial thromboplastin time tests under different storage conditions.
        Clin Chim Acta. 2000; 300: 13-21
        • Leeming D.R.
        • Craig S.
        • Stevenson K.J.
        • et al.
        The determination of INR in stored whole blood.
        J Clin Pathol. 1998; 51: 360-363
        • Froom P.
        • Abramova D.
        • Bar-El M.
        • et al.
        Reliability of delayed prothrombin time INR determinations in a central laboratory using off-site blood sampling.
        Clin Lab Haematol. 2001; 23: 189-192
        • Felfernig M.
        • Blaicher A.
        • Kettner S.C.
        • et al.
        Effects of temperature on partial thromboplastin time in heparinized plasma in vitro.
        Eur J Anaesthesiol. 2001; 18: 467-470
        • Boldt L.H.
        • Fraszl W.
        • Rocker L.
        • et al.
        Changes in the haemostatic system after thermoneutral and hyperthermic water immersion.
        Eur J Appl Physiol. 2008; 102: 547-554
        • Cavallini M.
        • Baruffaldi Preis F.W.
        • Casati A.
        Effects of mild hypothermia on blood coagulation in patients undergoing elective plastic surgery.
        Plast Reconstr Surg. 2005; 116 ([discussion: 322–3]): 316-321
        • Moriwaki Y.
        • Sugiyama M.
        Effect of fasting on coagulation factors in patients who undergo major abdominal surgery.
        Am Surg. 2010; 76: 168-171
        • Conaglen P.J.
        • Akowuah E.
        • Theodore S.
        • et al.
        Implications for cardiac surgery in patients with factor XII deficiency.
        Ann Thorac Surg. 2010; 89: 625-626
        • Favaloro E.J.
        • Zafer M.
        • Nair S.C.
        • et al.
        Evaluation of primary haemostasis in people with neurofibromatosis type 1.
        Clin Lab Haematol. 2004; 26: 341-345
        • Massarano A.A.
        • Wood A.
        • Tait R.C.
        • et al.
        Noonan syndrome: coagulation and clinical aspects.
        Acta Paediatr. 1996; 85: 1181-1185
        • Lapecorella M.
        • Mariani G.
        Factor VII deficiency: defining the clinical picture and optimizing therapeutic options.
        Haemophilia. 2008; 14: 1170-1175
        • Meeks S.L.
        • Abshire T.C.
        Abnormalities of prothrombin: a review of the pathophysiology, diagnosis, and treatment.
        Haemophilia. 2008; 14: 1159-1163
        • Seligsohn U.
        Factor XI deficiency in humans.
        J Thromb Haemost. 2009; 7: 84-87
        • Raffini L.J.
        • Niebanck A.E.
        • Hrusovsky J.
        • et al.
        Prolongation of the prothrombin time and activated partial thromboplastin time in children with sickle cell disease.
        Pediatr Blood Cancer. 2006; 47: 589-593
        • Borud L.J.
        • Matarasso A.
        • Spaccavento C.M.
        • et al.
        Factor XI deficiency: implications for management of patients undergoing aesthetic surgery.
        Plast Reconstr Surg. 1999; 104: 1907-1913
        • Katz K.
        • Tamary H.
        • Lahav J.
        • et al.
        Increased operative bleeding during orthopaedic surgery in patients with type I Gaucher disease and bone involvement.
        Bull Hosp Jt Dis. 1999; 58: 188-190
        • Menendez L.R.
        • Thommen V.D.
        Kasabach-Merritt syndrome complicating treatment of a closed femoral fracture.
        Clin Orthop Relat Res. 1995; : 185-188
        • Jackson J.M.
        • Marshall L.R.
        • Herrmann R.P.
        Passovoy factor deficiency in five Western Australian kindreds.
        Pathology. 1981; 13: 517-524
        • Jeske A.H.
        • Suchko G.D.
        Lack of a scientific basis for routine discontinuation of oral anticoagulation therapy before dental treatment.
        J Am Dent Assoc. 2003; 134: 1492-1497
      5. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators.
        Circulation. 1994; 90: 1631-1637
        • Douketis J.D.
        • Spyropoulos A.C.
        • Spencer F.A.
        • et al.
        Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines.
        Chest. 2012; 141: e326S-e350S
        • Garcia D.A.
        • Baglin T.P.
        • Weitz J.I.
        • et al.
        Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines.
        Chest. 2012; 141: e24S-e43S
        • Kearon C.
        • Akl E.A.
        • Comerota A.J.
        • et al.
        Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines.
        Chest. 2012; 141: e419S-e494S
        • Despotis G.J.
        • Levine V.
        • Goodnough L.T.
        Relationship between leukocyte count and patient risk for excessive blood loss after cardiac surgery.
        Crit Care Med. 1997; 25: 1338-1346
        • Puetz J.
        Fresh frozen plasma: the most commonly prescribed hemostatic agent.
        J Thromb Haemost. 2013; 11: 1794-1799
        • Rosendaal F.R.
        • Reitsma P.H.
        Is administering blood as useless as blood letting?.
        J Thromb Haemost. 2013; 11: 1793
        • Mannucci P.M.
        • Canciani M.T.
        • Mari D.
        • et al.
        The varied sensitivity of partial thromboplastin and prothrombin time reagents in the demonstration of the lupus-like anticoagulant.
        Scand J Haematol. 1979; 22: 423-432